Status:
UNKNOWN
Using AI to Select Women for Supplemental MRI in Breast Cancer Screening
Lead Sponsor:
Karolinska University Hospital
Collaborating Sponsors:
KTH Royal Institute of Technology
Region Stockholm
Conditions:
Breast Cancer
Eligibility:
FEMALE
40-74 years
Phase:
NA
Brief Summary
This is a prospective clinical trial aiming to determine the ability of an AI pipeline to identify women who would benefit from supplemental MRI in terms of decreasing the number of cancers having a s...
Detailed Description
All women attending mammography screening at Karolinska University Hospital will have their mammograms analyzed by AI (Figure 1). The specific AI-implementation (AI tool) in this study is a result of ...
Eligibility Criteria
Inclusion
- Complete four-view screening mammography examination
Exclusion
- Women in surveillance program referred from the hereditary cancer unit
- Breast implants
- Prior breast cancer
- Breast feeding
- MRI contraindication requiring radiologist assessment
- AI Tool unable to process mammograms due to technical reason
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04832594
Start Date
April 1 2021
End Date
July 1 2025
Last Update
October 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 17164